L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-life mobility insights from wearable sensors
Alessandro Zampogna, Luigi Borzì, Domiziana Rinaldi, Gabriele Imbalzano, Martina Patera, Marco Falletti, Carlo Alberto Artusi, Edoardo Bianchini, Leonardo Lopiano, Gabriella Olmo, Antonio Suppa · 2026
Read L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-life mobility insights from wearable sensors by Alessandro Zampogna, Luigi Borzì, Domiziana Rinaldi, Gabriele Imbalzano, Martina Patera, Marco Falletti, Carlo Alberto Artusi, Edoardo Bianchini, Leonardo Lopiano, Gabriella Olmo, Antonio Suppa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13310742.txt.
Description
Alessandro Zampogna and colleagues used wearable sensors to track walking in advanced Parkinson disease in a 2026 pilot study. Pills give the key drug in bursts, which can cause swings in movement and stray motions. A gut gel gives the drug in a steady flow, but its effect on daily walking had not been measured well.
Forty three patients took part, with 15 on the gel and 28 on best oral care. A waist sensor logged step length, speed, rhythm, freezing, and stray motion through the day. Gel users showed steadier steps and fewer swings, while stray motion time was alike. Sensors may help guide dose and follow up.
Catalog record
| CREATOR | Alessandro Zampogna, Luigi Borzì, Domiziana Rinaldi, Gabriele Imbalzano, Martina Patera, Marco Falletti, Carlo Alberto Artusi, Edoardo Bianchini, Leonardo Lopiano, Gabriella Olmo, Antonio Suppa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46041 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |